KINETO Lab

Home

Slide 1
NEW COMPOUNDS
GIVE A NEW HOPE

KINETO Lab’s expert team manages the whole process of drug development from target identification and validation through high throughput in vitro screenings to in vivo animal models studies

Slide 2
SERVICES
IN VITRO – IN VIVO – EX VIVO

Our mission is to enhance the quality of drug discovery and developmental concept of our partners by providing high quality services on various tumor models which allow you to design the most suitable study to prove a concept of your research, in order to reach the clinical stage faster

Slide 3
PDTX

Patient-derived tumor xenografts (PDTX) as clinically relevant models reflect tumor microenvironment of the patients, improving the reliability of translational research and predictability of clinical therapeutic response

15 years experienced cancer research biotech

We are a biotechnological research and CRO company which aims to use scientifically founded strategies to identify and validate new drug targets and use preclinical models for testing and developing mainly new anticancer and other anti-disease technologies and treatments.

Our company can fast, cost-effective and accurate prove a developmental concept of your research.

about us

KINETO Lab has extensive expertise and substantial experience in designing experiments to be used along the preclinical drug discovery pipeline for successful and effective research and development of anticancer drugs

research& development

PARTNERSHIP

KINETO Lab was participating in several successful projects in consortiums with industrial and academic institutions during the past years.
We believe in a collaborative model, based on strong partnerships, enabling us to share and provide our technologies and knowledge, enhancing the quality of research and developmental concept of our partners.

ARE YOU WILLING TO HAVE A TRUSTFUL PARTNER AND MAKE SUCCESSFUL COLLABORATION?

If you would like to become our partner, please contact us.

SERVICES

All the NEW COMPOUNDS successfully tested in preclinical phase GIVE NEW HOPE for better anticancer treatment.

KINETO Lab is an acknowledged expert providing tailored and unique methods to identify and validate new drug targets and to evaluate in vitro and in vivo activity of anticancer drugs in the preclinical drug discovery.

CONSULTANCY

Nowadays, polyhistorians in the classical sense no longer work effectively. Good quality scientific work requires cooperation between representatives of different disciplines.

We can provide you with assessment,
advice and ideas on biological issues

If you are a chemistry-related research laboratory involved in drug development, and if you are planning a new project, or already have ongoing projects where the biological aspects of the topic and feasibility and rationality arise, we can provide you with assessment, advice and ideas on biological issues to put your research on the scientific or business map.

CONSULTANCY

Nowadays, polyhistorians in the classical sense no longer work effectively. Good quality scientific work requires cooperation between representatives of different disciplines.

We can provide you with assessment,
advice and ideas on biological issues

If you are a chemistry-related research laboratory involved in drug development, and if you are planning a new project, or already have ongoing projects where the biological aspects of the topic and feasibility and rationality arise, we can provide you with assessment, advice and ideas on biological issues to put your research on the scientific or business map.

PRODUCTS

KINETO Lab produces an anti-human CD34 monoclonal antibody.

Additionally, we offer different samples from in vitro and in vivo experiments, for your further analyses.

ANTIBODY
KINETO Lab has the technology to produce anti-human CD34 monoclonal antibody, by immunizing BALB/c mice with purified recombinant extracellular domain of human CD34 protein, which binds for different types of stem cells and progenitor cells, as well as vascular endothelial cells and embryonic fibroblasts.
BIOLOGICAL SAMPLES

We can prepare and ship different samples from in vitro and in vivo experiments, for your further analyses.

Additionally, we can perform the molecular biology analysis service in our lab, providing you final results

NEWS

27/07/2023

We are pleased to announce that the first paper related to study of our Patient-Derived Tumor Xenograft (PDTX) models..

read more

13/07/2023

As a member of Magicbullet::Reloaded Consortium, KINETO Lab took a big part in the study..

read more

16/06/2023

The research proposal aims to deepen our understanding of the biological and clinical significance of molecular subtypes in small cell lung cancer (SCLC).

read more

CONTACTS

If you have any question regarding our research, services or PDTX models, and if you want to get in touch with us, fill the form or send us an e-mail on info@kinetolab.hu.

We are always open for your CV and application in case you would like to work in an innovative, dynamically growing cancer research-related biotech company in the future. If you think you could fit in KINETO Lab’s team, please contact us.

// Changes line color on blog-btn hover